Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:00:36 UTC |
---|
Update Date | 2021-09-14 14:57:58 UTC |
---|
HMDB ID | HMDB0013960 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Donepezil metabolite M4 |
---|
Description | Donepezil metabolite M4 is a metabolite of Donepezil. Donepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, and also marketed under the brand name DONEP by Alkem Pentacare, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the palliative treatment of Alzheimer's disease. Common side effects include gastrointestinal upset. It has an oral bioavailability of 100% and easily crosses the blood–brain barrier. Because it has a biological half-life of about 70 hours, it can be taken once a day. (Wikipedia) |
---|
Structure | COC1=C(OC)C=C2C(=O)C(CC3CCNCC3)CC2=C1 InChI=1S/C17H23NO3/c1-20-15-9-12-8-13(7-11-3-5-18-6-4-11)17(19)14(12)10-16(15)21-2/h9-11,13,18H,3-8H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
(2S,3R,4E)-2-Alkanamido-3-hydroxyoctadec-4-en-1-yl 3-O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-beta-D-galactopyranoside | HMDB | (2S,3R,4E)-2-Alkanamido-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2Right3)-beta-D-galactopyranoside | HMDB | (Acetyloxy)(tributyl)stannane (acd/name 4.0) | HMDB | (Acetyloxy)tributyl-stannane | HMDB | (Gal)1 (neu5ac)1 (cer)1 | HMDB | Acetoxytributyl-stannane | HMDB | Acetoxytributyl-tin | HMDB | Acetoxytributylstannane | HMDB | Acetoxytributyltin | HMDB | alpha-Neu5ac-(2Right3)-beta-D-gal-(1leftright1')-cer | HMDB | alpha-Neup5ac-(2Right3)-beta-D-galp-(1leftright1')-cer | HMDB | Ganglioside GM4 | HMDB | GM4 | HMDB | N-Acetyl-alpha-neuraminosyl-(2Right3)-beta-D-galactosylceramides | HMDB | N-Acetylneuraminyl-galactosylceramide | HMDB | Neu5ac-alpha2->3gal-beta1->1'cer | HMDB | Neu5ac-gal-beta1->1'cer | HMDB | NeuAcalpha2-3galbeta-cer | HMDB | TBTA | HMDB | Tin, tributyl-, acetate | HMDB | Tri-N-butyltin acetate | HMDB | Tributylacetoxystannane | HMDB | Tributylstannyl acetate | HMDB | Tributyltin acetate | HMDB | Tribuyltin acetate | HMDB |
|
---|
Chemical Formula | C17H23NO3 |
---|
Average Molecular Weight | 289.3694 |
---|
Monoisotopic Molecular Weight | 289.167793607 |
---|
IUPAC Name | 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one |
---|
Traditional Name | 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydroinden-1-one |
---|
CAS Registry Number | 56-36-0 |
---|
SMILES | COC1=C(OC)C=C2C(=O)C(CC3CCNCC3)CC2=C1 |
---|
InChI Identifier | InChI=1S/C17H23NO3/c1-20-15-9-12-8-13(7-11-3-5-18-6-4-11)17(19)14(12)10-16(15)21-2/h9-11,13,18H,3-8H2,1-2H3 |
---|
InChI Key | PGBZORAISITZTF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as indanones. Indanones are compounds containing an indane ring bearing a ketone group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Indanes |
---|
Sub Class | Indanones |
---|
Direct Parent | Indanones |
---|
Alternative Parents | |
---|
Substituents | - Indanone
- Anisole
- Aryl ketone
- Aryl alkyl ketone
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Ketone
- Secondary aliphatic amine
- Ether
- Secondary amine
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Amine
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 84.7 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.065 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Donepezil metabolite M4,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C)CC1)C2 | 2609.1 | Semi standard non polar | 33892256 | Donepezil metabolite M4,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C)CC1)C2 | 2702.8 | Standard non polar | 33892256 | Donepezil metabolite M4,1TMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C)CC1)C2 | 3343.1 | Standard polar | 33892256 | Donepezil metabolite M4,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C(C)(C)C)CC1)C2 | 2855.3 | Semi standard non polar | 33892256 | Donepezil metabolite M4,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C(C)(C)C)CC1)C2 | 2924.6 | Standard non polar | 33892256 | Donepezil metabolite M4,1TBDMS,isomer #1 | COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN([Si](C)(C)C(C)(C)C)CC1)C2 | 3499.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Donepezil metabolite M4 GC-MS (Non-derivatized) - 70eV, Positive | splash10-008a-7390000000-30b373dbaf089a113774 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Donepezil metabolite M4 GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Positive-QTOF | splash10-0006-0090000000-da28a41bd1b829d71a8e | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Positive-QTOF | splash10-0bu3-4970000000-801d3c0b32c93fd11165 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Positive-QTOF | splash10-0a59-9510000000-6d1d9c2e6a3d68e3dff0 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Negative-QTOF | splash10-000i-0090000000-e07661d76997ea63c579 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Negative-QTOF | splash10-000i-1190000000-7f3cb62ab8e739b13f28 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Negative-QTOF | splash10-005l-2960000000-4aff8e96600a8dcc0cd7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Negative-QTOF | splash10-000i-0090000000-1f5244541851cecc3419 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Negative-QTOF | splash10-000i-0090000000-ea661d63d95f0276ff50 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Negative-QTOF | splash10-017i-0190000000-bbc4b50b5f9509e31d35 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 10V, Positive-QTOF | splash10-0006-0090000000-33b322e33c44f750998f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 20V, Positive-QTOF | splash10-0006-0090000000-a157f4737fa76857bd9f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Donepezil metabolite M4 40V, Positive-QTOF | splash10-08g4-2960000000-aa5279093d72dcc7f374 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|